167

Cardiovascular Diseases
Focuses on heart and vascular health.
Sub Categories on Cardiovascular Diseases
Latest Articles
Culturally tailored food intervention delivers meaningful blood pressure reductions, finds study

Culturally tailored food intervention delivers meaningful blood pressure reductions, finds study

byAmerican College of CardiologyCredit: Antoni Shkraba Studio from PexelsBlack and Hispanic adults with high blood pressure (hypertension) who received a culturally tailored food-based intervention wi

Culturally tailored food intervention delivers meaningful blood pressure reductions, finds study

byAmerican College of CardiologyCredit: Antoni Shkraba Studio from PexelsBlack and Hispanic adults with high blood pressure (hypertension) who received a culturally tailored food-based intervention wi
No benefit for delayed reperfusion with left-ventricular support in patients with large heart attacks

No benefit for delayed reperfusion with left-ventricular support in patients with large heart attacks

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainThe first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percut

No benefit for delayed reperfusion with left-ventricular support in patients with large heart attacks

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainThe first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percut
Trial finds no clear added benefit of catheter ablation for preventing recurrent stroke in atrial fibrillation patients

Trial finds no clear added benefit of catheter ablation for preventing recurrent stroke in atrial fibrillation patients

byKumamoto UniversitySchematic overview of the nationwide STABLED randomized clinical trial comparing standard anticoagulant therapy alone with anticoagulant therapy plus catheter ablation in patients

Trial finds no clear added benefit of catheter ablation for preventing recurrent stroke in atrial fibrillation patients

byKumamoto UniversitySchematic overview of the nationwide STABLED randomized clinical trial comparing standard anticoagulant therapy alone with anticoagulant therapy plus catheter ablation in patients
Triglyceride-lowering drug does not affect plaque in arteries at one year in patients with elevated triglycerides: Study

Triglyceride-lowering drug does not affect plaque in arteries at one year in patients with elevated triglycerides: Study

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainDespite experiencing significant reductions in triglycerides, patients with triglycerides over 150 mg/dL and a high risk of atheroscle

Triglyceride-lowering drug does not affect plaque in arteries at one year in patients with elevated triglycerides: Study

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainDespite experiencing significant reductions in triglycerides, patients with triglycerides over 150 mg/dL and a high risk of atheroscle
ACC: Expanding eligibility for low-income subsidies can improve CVD medication adherence

ACC: Expanding eligibility for low-income subsidies can improve CVD medication adherence

by Elana GotkineExpanding eligibility for full low-income subsidies (LIS) to include those with incomes between 135% and 150% of the federal poverty level (FPL) is associated with a reduction in cost-

ACC: Expanding eligibility for low-income subsidies can improve CVD medication adherence

by Elana GotkineExpanding eligibility for full low-income subsidies (LIS) to include those with incomes between 135% and 150% of the federal poverty level (FPL) is associated with a reduction in cost-
Less invasive method to assess coronary flow similar to gold standard, study shows

Less invasive method to assess coronary flow similar to gold standard, study shows

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainA novel, minimally invasive computer software-based method that uses artificial intelligence to determine whether plaques in a coronar

Less invasive method to assess coronary flow similar to gold standard, study shows

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainA novel, minimally invasive computer software-based method that uses artificial intelligence to determine whether plaques in a coronar
Direct comparison shows stroke protection devices during TAVR perform alike

Direct comparison shows stroke protection devices during TAVR perform alike

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainIn the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter aortic valv

Direct comparison shows stroke protection devices during TAVR perform alike

byAmerican College of CardiologyCredit: Pixabay/CC0 Public DomainIn the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter aortic valv
Study finds no significant benefit of spironolactone in HFpEF or HFmrEF

Study finds no significant benefit of spironolactone in HFpEF or HFmrEF

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainA trial testing the aldosterone blocker spironolactone in patients with heart failure with preserved ejection fraction (HFpEF) and hea

Study finds no significant benefit of spironolactone in HFpEF or HFmrEF

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainA trial testing the aldosterone blocker spironolactone in patients with heart failure with preserved ejection fraction (HFpEF) and hea
Intensive LDL lowering with evolocumab reduced first heart attack or stroke in diabetes

Intensive LDL lowering with evolocumab reduced first heart attack or stroke in diabetes

byMass General BrighamCredit: www.kaboompics.com from PexelsMass General Brigham researchers found that the intensive cholesterol-lowering therapy evolocumab reduced the risk of a first major cardiova

Intensive LDL lowering with evolocumab reduced first heart attack or stroke in diabetes

byMass General BrighamCredit: www.kaboompics.com from PexelsMass General Brigham researchers found that the intensive cholesterol-lowering therapy evolocumab reduced the risk of a first major cardiova
Long COVID is associated with increased risk of cardiovascular disease

Long COVID is associated with increased risk of cardiovascular disease

byKarolinska InstitutetCredit: SHVETS production from PexelsPeople with long COVID are at increased risk of developing cardiovascular disease, according to a new study from Karolinska Institutetpublis

Long COVID is associated with increased risk of cardiovascular disease

byKarolinska InstitutetCredit: SHVETS production from PexelsPeople with long COVID are at increased risk of developing cardiovascular disease, according to a new study from Karolinska Institutetpublis
Dual imaging identifies cause of heart attack in patients without blocked arteries

Dual imaging identifies cause of heart attack in patients without blocked arteries

by Katie Ullman,NYU Langone HealthCredit: Unsplash/CC0 Public DomainWhen Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it could be a heart attack. S

Dual imaging identifies cause of heart attack in patients without blocked arteries

by Katie Ullman,NYU Langone HealthCredit: Unsplash/CC0 Public DomainWhen Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it could be a heart attack. S
Seeing artery calcium may change behavior, keeping 71% on statins at eight years

Seeing artery calcium may change behavior, keeping 71% on statins at eight years

byUniversity of TasmaniaCredit: Pixabay/CC0 Public DomainCould showing someone a picture of plaque building up in their arteries be enough to save their life? That's the question driving the lates

Seeing artery calcium may change behavior, keeping 71% on statins at eight years

byUniversity of TasmaniaCredit: Pixabay/CC0 Public DomainCould showing someone a picture of plaque building up in their arteries be enough to save their life? That's the question driving the lates